Pfizer · Total Non-Current Liabilities

Latest reported$84.40Bperiod endingDec 31, 2025

PFE FY Total Non-Current Liabilities ($575.90M → $84.40B)

Annual total non-current liabilities

High-resolution chart · PNG

PFE total non-current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Total Non-Current Liabilities — Annual fiscal periods (USD)
Period ending	Total Non-Current Liabilities (USD)
Dec 31, 2025	84,401,000,000
Dec 31, 2024	81,904,000,000
Dec 31, 2023	89,419,000,000
Dec 31, 2022	59,151,000,000
Dec 31, 2021	61,343,000,000
Dec 31, 2020	64,836,000,000
Dec 31, 2019	66,843,000,000
Dec 31, 2018	63,806,000,000
Dec 31, 2017	69,714,000,000
Dec 31, 2016	80,660,000,000
Dec 31, 2015	72,984,000,000
Dec 31, 2014	74,357,000,000
Dec 31, 2013	72,115,000,000
Dec 31, 2012	74,934,000,000
Dec 31, 2011	76,472,000,000
Dec 31, 2010	78,140,000,000
Dec 31, 2009	85,278,000,000
Dec 31, 2008	26,399,000,000
Dec 31, 2007	28,309,000,000
Dec 31, 2006	22,015,000,000
Dec 31, 2005	22,794,000,000
Dec 31, 2004	28,342,000,000
Dec 31, 2003	27,489,000,000
Dec 31, 2002	7,851,000,000
Dec 31, 2001	7,131,000,000
Dec 31, 2000	5,453,000,000
Dec 31, 1999	5,526,000,000
Dec 31, 1998	2,300,000,000
Dec 31, 1997	2,064,000,000
Dec 31, 1996	2,023,000,000
Dec 31, 1995	1,988,900,000
Dec 31, 1994	1,909,900,000
Dec 31, 1993	1,982,500,000
Dec 31, 1992	1,619,200,000
Dec 31, 1991	1,153,400,000
Dec 31, 1990	814,400,000
Dec 31, 1989	853,300,000
Dec 31, 1988	992,200,000
Dec 31, 1987	1,083,600,000
Dec 31, 1986	577,800,000
Dec 31, 1985	575,900,000